Acadian Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $139,450 - $155,102	-1,617 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$71.83 - $95.48 $22.4 Million - $29.8 Million	-311,851 Reduced 99.48%	1,617 $149,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $500,155 - $629,971	-7,465 Reduced 2.33%	313,468 $22.9 Million
Q3 2020 Nov 09, 2020	SELL	$55.23 - $79.93 $1.05 Million - $1.52 Million	-18,955 Reduced 5.58%	320,933 $24.9 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $265,458 - $500,854	-8,790 Reduced 2.52%	339,888 $18.9 Million
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $3.04 Million - $4.71 Million	-122,181 Reduced 25.95%	348,678 $10.3 Million
Q4 2019 Feb 06, 2020	SELL	$25.43 - $36.67 $8.41 Million - $12.1 Million	-330,592 Reduced 41.25%	470,859 $17 Million
Q3 2019 Nov 07, 2019	BUY	$23.0 - $27.97 $901,462 - $1.1 Million	39,194 Added 5.14%	801,451 $21.8 Million
Q2 2019 Aug 08, 2019	BUY	$22.81 - $28.48 $17.4 Million - $21.7 Million	762,257 New	762,257 $18.3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.